Academician Wang Jingkang Calls for Urgent Improvement of China's Industrial Crystallization Level
March 11 14:19:58, 2021
At the second China International Crystal Conference held on September 21-25 and the key technology seminars for China's industry crystallization and pharmaceutical industry, Wang Jingkang, chairman of the Organizing Committee and member of the Chinese Academy of Engineering, called for the upgrading of China's industrial crystallographic technology as soon as possible. Enhance the international competitiveness of China's pharmaceutical industry. Wang Jingkang said that industrial crystallization is an interdisciplinary and cross-disciplinary multidisciplinary cross-cutting technology with broad market prospects in many fields such as pharmaceuticals, fine chemicals, health foods, functional materials, etc. It is the forefront of international competition in the 21st century and the battleground for military strategists. . China is a big manufacturing country, but it is not yet a manufacturing powerhouse. In particular, the pharmaceutical industry only exports APIs. At present, there is not yet a single civilian drug that enters the US Food and Drug Administration (FDA), indicating that the level of our drug production line needs to be improved. She said that raw material medicines can be exported for foreign exchange, but they cannot be satisfied with being a major exporter of primary products. If the added value of the primary product is 1, then the added value of the final functional product is 100, which is why foreign companies come to China to build a primary product factory, and then return the primary product to deep processing and then sell it back. If you do not catch up with you, then huge profits have been earned by others. Academician Wang Jingkang emphasized that in order to achieve the export of pharmaceutical products, the industrial crystal production line must improve. However, there is still a lot of work to be done to improve the crystallization of China's information technology industry. She appealed to relevant parties to pay attention to applied basic research in this field, increase investment in R&D, combine production, study and research to overcome key technologies, and meet the challenges of international competition with new technologies and processes of China's own intellectual property rights. The conference was jointly sponsored by Tianjin University, the Chinese Academy of Engineering Chemical Metallurgy Department, the Chinese Chemical Society, and the China Medical Technology Market Association. It aims to further promote exchanges with international academic communities in the fields of research, development, and application of industrial crystallization and pharmaceutical key technologies, and at the same time strengthen the design and automation control of Chinese industrial pharmaceutical companies as well as key pharmaceutical technology and international research institutes. Cooperation. More than 100 experts, as well as companies and scientific and technological personnel attended the meeting.